Weijing Sun, MD, discusses a major topic in locally advanced gastroesophageal junction adenocarcinoma covered at the 2018 ISGIO Annual Conference in Arlington, Virginia.
Weijing Sun, MD, gastrointestinal oncologist at the University of Kansas School of Medicine, discusses a major topic in locally advanced gastroesophageal junction (GEJ) adenocarcinoma covered at the 2018 ISGIO Annual Conference in Arlington, Virginia.
At the conference, experts debated the role of radiation therapy in this patient population, Sun says. Two studies looked at different preoperative therapy options with encouraging data both with and without radiation.
The FLOT study explored a regimen of fluorouracil, leucovorin, oxaliplatin, and docetaxel for this patient population, without radiation. The CROSS study looked at the combination of carboplatin and paclitaxel with radiation.
Durvalumab Plus Chemo Continues to Improve Survival in Biliary Tract Cancer
April 16th 2024Results from a 3-year follow-up of the TOPAZ-1 trial showed that treatment with durvalumab plus chemotherapy in advanced biliary tract cancer continued to improve overall survival vs chemotherapy alone.
Read More
The Impact of the Gut Microbiome in Young Patients With Colorectal Cancer
February 15th 2021In season 2, episode 2 of Targeted Talks, Cathy Eng, MD, speaks with Benjamin Weinberg, MD, about the gut microbiome, and how the presence of certain microbiota impact the onset and intensity of disease as well as the potential response to certain treatments.
Listen